These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 28633318)
21. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices. Crouch DJ; Walsh JM; Cangianelli L; Quintela O Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979 [TBL] [Abstract][Full Text] [Related]
22. First evaluation of the possibility of testing for drugged driving using exhaled breath sampling. Beck O; Ullah S; Kronstrand R Traffic Inj Prev; 2019; 20(3):238-243. PubMed ID: 31039047 [No Abstract] [Full Text] [Related]
23. Drugs and driving prior to cannabis legalization: A 5-year review from DECP (DRE) cases in the province of Quebec, Canada. Vaillancourt L; Viel E; Dombrowski C; Desharnais B; Mireault P Accid Anal Prev; 2021 Jan; 149():105832. PubMed ID: 33220606 [TBL] [Abstract][Full Text] [Related]
24. Analytical reliability of four oral fluid point-of-collection testing devices for drug detection in drivers. Scherer JN; Schuch JB; Rabelo-da-Ponte FD; Silvestrin R; Ornell R; Sousa T; Limberger RP; Pechansky F Forensic Sci Int; 2020 Oct; 315():110434. PubMed ID: 32758788 [TBL] [Abstract][Full Text] [Related]
25. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Verstraete AG Forensic Sci Int; 2005 Jun; 150(2-3):143-50. PubMed ID: 15944054 [TBL] [Abstract][Full Text] [Related]
26. User experience and operational feasibility of four point-of-collection oral fluid drug-testing devices according to Brazilian traffic agents. Pechansky F; Scherer JN; Schuch JB; Roglio V; Telles YM; Silvestrin R; Pasa G; Sousa T Traffic Inj Prev; 2019; 20(1):30-36. PubMed ID: 30822144 [TBL] [Abstract][Full Text] [Related]
27. Suitability of SoToxa® Oral Fluid Screening Over Time: Re-Examination of Drugged Driving in Wisconsin. Savage T; Sanders T; Pieters R; Miles A; Barkholtz H J Anal Toxicol; 2022 Oct; 46(8):825-834. PubMed ID: 35767245 [TBL] [Abstract][Full Text] [Related]
28. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072 [TBL] [Abstract][Full Text] [Related]
29. DUID prevalence in Colorado's DUI citations. Wood E; Salomonsen-Sautel S J Safety Res; 2016 Jun; 57():33-8. PubMed ID: 27178077 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of Dräger DrugTest 5000 in a Naturalistic Setting. Gjerde H; Clausen GB; Andreassen E; Furuhaugen H J Anal Toxicol; 2018 May; 42(4):248-254. PubMed ID: 29409046 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis. Strano-Rossi S; Castrignanò E; Anzillotti L; Serpelloni G; Mollica R; Tagliaro F; Pascali JP; di Stefano D; Sgalla R; Chiarotti M Forensic Sci Int; 2012 Sep; 221(1-3):70-6. PubMed ID: 22554872 [TBL] [Abstract][Full Text] [Related]
32. Drugs of abuse in oral fluid collected by two different sample kits--stability testing and validation using ultra performance tandem mass spectrometry analysis. Lund HM; Øiestad EL; Gjerde H; Christophersen AS J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3367-77. PubMed ID: 21962269 [TBL] [Abstract][Full Text] [Related]
33. A review of drug abuse in recently reported cases of driving under the influence of drugs (DUID) in Asia, USA, and Europe. Ji Kwon N; Han E Forensic Sci Int; 2019 Sep; 302():109854. PubMed ID: 31255839 [TBL] [Abstract][Full Text] [Related]
34. Benzodiazepine whole blood concentrations in cases with positive oral fluid on-site screening test results using the DrugWipe(®) single for benzodiazepines. Blencowe T; Vimpari K; Lillsunde P J Anal Toxicol; 2011 Jul; 35(6):349-56. PubMed ID: 21740691 [TBL] [Abstract][Full Text] [Related]
35. Cocaine and benzoylecgonine oral fluid on-site screening and confirmation. Ellefsen KN; Concheiro M; Pirard S; Gorelick DA; Huestis MA Drug Test Anal; 2016; 8(3-4):296-303. PubMed ID: 26968560 [TBL] [Abstract][Full Text] [Related]
36. Drugs and driving. Walsh JM; de Gier JJ; Christopherson AS; Verstraete AG Traffic Inj Prev; 2004 Sep; 5(3):241-53. PubMed ID: 15276925 [TBL] [Abstract][Full Text] [Related]
37. A review of suspected cases of driving under the influence of drugs (DUID) involved in traffic accidents in Istanbul (Turkey). Acar F; Asirdizer M; Aker RG; Kucukibrahimoglu EE; Ates I; Erol Y; Sahin A J Forensic Leg Med; 2013 Aug; 20(6):626-31. PubMed ID: 23910848 [TBL] [Abstract][Full Text] [Related]
38. Conventional and alternative matrices for driving under the influence of cannabis: recent progress and remaining challenges. Wille SM; Ramírez-Fernandez Mdel M; Samyn N; De Boeck G Bioanalysis; 2010 Apr; 2(4):791-806. PubMed ID: 21083274 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine. Tang MHY; Ching CK; Poon S; Chan SSS; Ng WY; Lam M; Wong CK; Pao R; Lau A; Mak TWL Forensic Sci Int; 2018 May; 286():113-120. PubMed ID: 29574346 [TBL] [Abstract][Full Text] [Related]
40. Usefulness of roadside urine drug screening in drivers suspected of driving under the influence of drugs (DUID). Raes E; Verstraete AG J Anal Toxicol; 2005 Oct; 29(7):632-6. PubMed ID: 16419392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]